Uni Eropa - Lituavi - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - karcinoma, nesmulkiųjų ląstelių skausmas - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Uni Eropa - Lituavi - EMA (European Medicines Agency)

pfizer europe ma eeig - glasdegib maleate - leukemija, mieloidas, ūmus - antinavikiniai vaistai - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

Lituania - Lituavi - SMCA (Valstybinė vaistų kontrolės tarnyba)

le vet b.v. (nyderlandai) - tabletės - vienoje tabletėje yra: levotiroksino natrio druskos - 600 µg (atitinka 583 µg levotiroksino). - šunims ir katėms pirminei ir antrinei hipotirozei gydyti.

Lituania - Lituavi - SMCA (Valstybinė vaistų kontrolės tarnyba)

le vet b.v. (nyderlandai) - tabletės - vienoje tabletėje yra: levotiroksino natrio druskos - 200 µg (atitinka 194 µg levotiroksino). - šunims ir katėms pirminei ir antrinei hipotirozei gydyti.

Lituania - Lituavi - SMCA (Valstybinė vaistų kontrolės tarnyba)

livisto int'l, s.l. (ispanija) - tabletės - levotiroksino natrio druskos 800 μg (atitinka levotiroksino 778 μg). - pirminei ir antrinei hipotirozei gydyti.

Uni Eropa - Lituavi - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Uni Eropa - Lituavi - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamivudine, tenofovir disoproxil fumarate - Živ infekcijos - antivirusiniai vaistai Živ infekcijos gydymui, deriniai - delstrigo fluorouracilu ir folino suaugusiųjų yra užsikrėtę Živ 1 be praeities ar dabarties įrodymų atsparumo nnati klasė, lamivudine, ar tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Uni Eropa - Lituavi - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Uni Eropa - Lituavi - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresantai - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

Uni Eropa - Lituavi - EMA (European Medicines Agency)

hra pharma rare diseases - ketokonazolo - cushingo sindromas - antimycotics sisteminiam vartojimui - ketokonazolo hra skiriamas endogeninio cushingo sindromo gydymui suaugusiems ir paaugliams, vyresniems nei 12 metų.